Logo image of CINR

CINER RESOURCES LP (CINR) Stock Fundamental Analysis

NYSE:CINR - New York Stock Exchange, Inc. -

20.31  -0.03 (-0.15%)

Fundamental Rating

2

Overall CINR gets a fundamental rating of 2 out of 10. We evaluated CINR against 85 industry peers in the Chemicals industry. CINR has a bad profitability rating. Also its financial health evaluation is rather negative. CINR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CINR had positive earnings in the past year.
CINR Yearly Net Income VS EBIT VS OCF VS FCFCINR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 50M 100M 150M

1.2 Ratios

Industry RankSector Rank
ROA 3.45%
ROE 9.59%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CINR Yearly ROA, ROE, ROICCINR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 10 20 30

1.3 Margins

Industry RankSector Rank
OM 9.42%
PM (TTM) 3.84%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CINR Yearly Profit, Operating, Gross MarginsCINR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 5 10 15 20 25

More info and screens

2

2. Health

2.1 Basic Checks

CINR has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for CINR is higher compared to a year ago.
CINR Yearly Shares OutstandingCINR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 5M 10M 15M 20M
CINR Yearly Total Debt VS Total AssetsCINR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 100M 200M 300M 400M

2.2 Solvency

CINR has a Debt/Equity ratio of 0.65. This is a neutral value indicating CINR is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CINR Yearly LT Debt VS Equity VS FCFCINR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 50M 100M 150M

2.3 Liquidity

A Current Ratio of 3.42 indicates that CINR has no problem at all paying its short term obligations.
CINR has a Quick Ratio of 2.94. This indicates that CINR is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 3.42
Quick Ratio 2.94
CINR Yearly Current Assets VS Current LiabilitesCINR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.56% over the past year.
Measured over the past years, CINR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -25.80% on average per year.
The Revenue has grown by 17.70% in the past year. This is quite good.
The Revenue has been decreasing by -4.21% on average over the past years.
EPS 1Y (TTM)9.56%
EPS 3Y9.07%
EPS 5Y-25.8%
EPS Q2Q%220.11%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y-7.61%
Revenue growth 5Y-4.21%
Sales Q2Q%38.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
CINR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.47% yearly.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.06%
Revenue Next 2Y8.47%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CINR Yearly Revenue VS EstimatesCINR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M 500M
CINR Yearly EPS VS EstimatesCINR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 0.5 1 1.5 2 2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 21.61, the valuation of CINR can be described as rather expensive.
Compared to an average S&P500 Price/Earnings ratio of 26.68, CINR is valued at the same level.
Industry RankSector Rank
PE 21.61
Fwd PE N/A
CINR Price Earnings VS Forward Price EarningsCINR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.76
CINR Per share dataCINR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 12.78%, CINR is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.36, CINR pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.78%

5.2 History

The dividend of CINR decreases each year by -46.88%.
CINR has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-46.88%
Div Incr YearsN/A
Div Non Decr YearsN/A
CINR Yearly Dividends per shareCINR Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 0.5 1 1.5 2

5.3 Sustainability

The Dividend Rate of CINR has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2YN/A
EPS Next 3YN/A
CINR Yearly Income VS Free CF VS DividendCINR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 20M 40M 60M 80M 100M

More info and screens

CINER RESOURCES LP

NYSE:CINR (2/28/2022, 8:04:28 PM)

20.31

-0.03 (-0.15%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)05-02 2022-05-02
Inst Owners0.01%
Inst Owner Change0%
Ins Owners74.33%
Ins Owner Change0%
Market Cap401.73M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 12.78%
Yearly Dividend0.34
Dividend Growth(5Y)-46.88%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 21.61
Fwd PE N/A
P/S 0.82
P/FCF N/A
P/OCF N/A
P/B 2.06
P/tB N/A
EV/EBITDA 6.76
EPS(TTM)0.94
EY4.63%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS24.65
BVpS9.86
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.45%
ROE 9.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 9.42%
PM (TTM) 3.84%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.42
Quick Ratio 2.94
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.56%
EPS 3Y9.07%
EPS 5Y-25.8%
EPS Q2Q%220.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.7%
Revenue growth 3Y-7.61%
Revenue growth 5Y-4.21%
Sales Q2Q%38.09%
Revenue Next Year12.06%
Revenue Next 2Y8.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A